Efficas Inc. Launches New Product and Website for Allergy and Asthma Sufferers
BOULDER, Colo., July 10 /PRNewswire/ — Efficas Inc., a health science and technology development company, announced the launch of its berry-flavored Efficas Care(TM) and extensive online resources for allergy and asthma sufferers. Efficas Care is a non-prescription medical food clinically proven to safely and effectively inhibit the production of leukotrienes, inflammatory substances produced by the body and known to cause allergy and asthma symptoms.
Allergic individuals tend to produce higher levels of leukotrienes when faced with an allergen than do non-allergic individuals. While there are pharmaceutical products that work by interfering with the uptake of leukotrienes, Efficas Care is the first “nutritional therapeutic” approach to reduce leukotriene production and help manage allergy and asthma symptoms, including sinus congestion, sneezing, itchy, watery eyes, coughing, wheezing and shortness of breath.
“We are thrilled to offer asthma and allergy sufferers a safe and effective medical food, with no clinically significant side effects, as an option for the dietary management of their symptoms,” said Mark A. Braman, President and CEO, Efficas Inc.
Medical foods are specially-formulated for the dietary management of a disease with distinctive nutritional needs that cannot be met by a normal diet alone. Each convenient daily packet of Efficas Care delivers a tablespoon of a unique formulation containing two essential fatty acids found in nature (750mg GLA and 500mg EPA) in a precise ratio to effectively block the production of leukotrienes. The GLA and EPA nutritional bioactives are delivered in a patented emulsion that makes them significantly more bioavailable than the average over-the-counter oil capsule or supplement. Efficas Care’s unique form makes it practical to get enough of the essential fatty acids for effective allergy and asthma symptom relief. In comparison, it would take 17 one-gram capsules to provide the same levels of essential fatty acids provided by each Efficas Care packet. Efficas Care can be taken alone or mixed with foods or beverages such as smoothies or yogurt.
“In a clinical trial, when added to a daily diet, the Efficas Care formula suppressed the production of leukotrienes in 75 percent of asthmatics,” said Dr. Dean Stull, Chief Science Officer, Efficas Inc. “In another research study more than 70 percent of allergy and asthma sufferers reported that Efficas Care, when added to their treatment, relieved most or all of their symptoms. Overall, 65 percent of asthma and allergy sufferers reported a significant improvement in their quality of life.”
“Our mission is to be a leader in bioactive solutions that measurably improve the quality of life of people with immune diseases.” said Braman. “Efficas Care is our first patented, nutritional product meant for the dietary management of allergy and asthma. In addition, we designed our website to serve as an extensive online resource for asthma and allergy sufferers to help them with the daily management of their allergic conditions.”
Efficas.com now houses over forty separate pages of practical information for allergy and asthma sufferers such as how to minimize exposure to allergens, how to check local pollen counts and tips for living with pets most likely to incite allergic attacks. Consumers who visit the site will also have the option to sign up for free monthly e-newsletter consisting of unique and original tips. Efficas Care is currently available for purchase online at Efficas.com.
About Efficas Inc.:
Efficas Inc., located in Boulder, Colorado, is a health science and technology development company committed to developing science-based consumer products for the nutritional management of the immune system both for humans and pets.
With a mission linked to the origins of its corporate name, efficacy, the company is committed to bringing to market products that are both safe and proven to provide quality of life benefits. Efficas has built its research, development and commercialization activities on the foundation of rigorous science, including clinical trials and safety testing for each of its patented nutritional bioactives. For more information, please visit Efficas’ web site, http://www.efficas.com/.
Efficas Inc.
CONTACT: Amy Cone Burrell of Efficas Inc., +1-303-381-2068, oraburrell@efficas.com, or Shauna Wreschner of Emanate Public Relations,+1-212-805-8021, or shauna.wreschner@emanatepr.com, for Efficas Inc.
Web site: http://www.efficas.com/